Clinical trial
Stem Cell Transplantation for Patients With Graft Failure Following an…
NCT00048399 · Baylor College of Medicine, Other · Terminated
Key facts
| NCT number | NCT00048399 |
|---|---|
| Title | Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H |
| Official title | Phase I/II Study of Allogeneic Stem Cell Transplantation For Patients With Graft Failure Following Allogeneic Transplantation Using MHC Identical or Near Identical Donors and Submyeloablative Conditioning With CAMPATH 1H (CAMGRAFT) |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Graft Failure |
| Intervention type | Drug, Procedure |
| Interventions | Fludarabine, CAMPATH 1H, FK506, Stem Cell Transplantation |
| Enrollment | 40 |
| Start date | Dec 1, 2000 |
| Primary completion | Oct 31, 2003 |
| Completion | Oct 31, 2003 |
| First posted | Nov 1, 2002 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: